Cell Cryopreservation Market

Cell Cryopreservation Market - Size, Share,
Growth, Outlook, and Opportunity Analysis,
2018-2026
Cryopreservation is a technique used to preserve various cells, tissue, organelles, and other
biological products by cooling them at very low temperatures. Cryopreservation uses very low
temperatures to preserve structurally intact living cells and tissues for a prolonged time period. Stem
cells and various valuable tissues used in research studies and many other medical application are
preserved by cryopreservation, as they cannot be stored by simple cooling for a long time. The
cryopreservation procedure involves mixing of cryoprotective agents (CPAs) with cells or tissues
before cooling, then the cells or tissues are cooled at very low temperature and stored.
Cryopreservation has a wide application in preservation of stem cells, oocytes, embryos sperm,
semen, testicular tissue, and hepatocytes.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1698
Launches of novel cryopreservation systems are expected to be major driver for growth of global cell
cryopreservation market. For instance, in 2015, AMS Biotechnology Limited launched its new StemCellbanker, a GMP grade cell cryopreservation media. Stem-Cellbanker is a freezing solution, used
for preservation of stem cell, iPS cell and other cells. In 2014, Asymptote Ltd, a Cambridge-based
cryopreservation specialists launched its unique range of liquid nitrogen free controlled rate freezers
especially designed for the needs of regenerative medicine at the annual meeting of the International
Society for Cellular Therapy (ISCT) held in Paris.
Cell Cryopreservation Market Regional Analysis
North America is expected to hold a dominant position in global cell cryopreservation market,
owing to presence of key players in the region and frequent launches of latest cryopreservation
media. For instance, in 2014, irvine scientific a U.S.-based innovator and manufacturer of cell
culture media expanded its cell cryopreservation media product portfolio with the launch of
PRIME-XV FreezIS DMSO-Free, a Dimethyl Sulfoxide (DMSO) and animal-derived components free
cryopreservation solution for Human Mesenchymal Stem/Stromal Cells (MSCs). Furthermore, the
Europe is expected to witness a significant growth in global cell cryopreservation market over
the forecast period, owing to strategic collaborations and acquisition by the key players in the
region. For instance, in 2017, U.K.-based GE healthcare acquired Asymptote Ltd., with this
strategic acquisition GE healthcare has expanded its product portfolio with the Asymptote Ltd’s
cell cryopreservation system.
Report includes chapters which deeply display the following deliverable about industry :
• Cell Cryopreservation Market Research Objective and Assumption
• Cell Cryopreservation Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Cell Cryopreservation Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cell Cryopreservation Market, By Regions
• Cell Cryopreservation Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cell Cryopreservation Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Cell Cryopreservation Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cell Cryopreservation Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Cell Cryopreservation Market Key Players:
Key players operating in cell cryopreservation market include Merck KGaA, GE
Healthcare, Thermo Fisher Scientific, Inc., AMS Biotechnology Limited, Nippon
Genetics, VitriCell SA, Miltenyi Biotec, Mediatech, Inc., BioLifeSolutions, Inc., HiMedia
Laboratories, and PromoCell GmbH.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1698
Cell Cryopreservation Market Taxonomy:
The global cell cryopreservation market is segmented on the basis of product type, application,
end user, and region
By Product Type• Cryoprotective Agents
• Glycerol
• DMSO
• Others
• Freezers
• Others
By Application•
•
•
•
•
Stem cells
Oocytes and embryos
Sperm, semen, and testicular tissue
Hepatocytes
Others
By End User• Pharmaceutical and Biotechnology companies
• Research Institutes
• Others
By Region•
•
•
•
•
•
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Download Report